FEMALE BREAST CANCER2009-2013

JOHNS HOPKINS HOSPITALCANCER REGISTRY

Prepared by Theresa SanLorenzo-Caswell, CTR10/03/20014

HEAD/NECK OF THE SKINANALYTIC vs. NON-ANALYTIC by YEARN = 1800

2009 2010 2011 2012 2013

ANALYTIC (2962) 624 562 611 611 554

NON-ANALYTIC (354) 67 63 52 85 87

50

150

250

350

450

550

650

NU

MB

ER

FEMALE BREAST CANCER2009-2013 ALL CASES = 3316ANALYTIC vs. NON-ANALYTIC

HEAD/NECK OF THE SKINAGE AT DIAGNOSIS, ALL CASESN = 1800

0 - 19 20 - 29 30 - 39 40 - 49 50 - 59 60 - 69 70 - 79 80+

FEMALE 2 38 265 804 945 766 376 120

50

150

250

350

450

550

650

750

850

950

NU

MB

ERFEMALE BREAST CANCER2009-2013 ALL CASES = 3316AGE AT DIAGNOSIS

FEMALE BREAST CANCER2009-2013 ALL CASES = 3316RACE/ETHNICITY

CAUCASIAN AFRICAN AMERICAN HISPANIC OTHER

FEMALE 2319 734 57 206

250

750

1250

1750

2250

NU

MB

ER

FEMALE BREAST CANCER2009-2013 ALL CASES = 3316STATE OF RESIDENCE AT DIAGNOSIS

MD69.1%

VA9.6%

PA7.1%

OUT OF COUNTRY1.8%

DE1.9%

WV1.5%

DC1.5%

FL1.3%

ALL OTHER STATES6.3%

FEMALE BREAST CANCER2009-2013 ALL MARYLAND CASES = 2294COUNTY OF RESIDENCE AT DIAGNOSIS

BALTIMORE CO.22.8%

BALTIMORE CITY22.1%

MONTGOMERY CO.10.4%

HOWARD CO.8.4%

PRINCE GEORGES CO.8.1%

ANNE ARUNDEL CO.6.1%

HARFORD CO.6.0%

CARROLL CO.3.0%

ALL OTHER COUNTIES13.3%

FEMALE BREAST CANCER2009-2013 ANALYTIC CASES = 2828*AJCC STAGE

AJCC 019.6%

AJCC I39.0%

AJCC II25.9%

AJCC III10.6%

AJCC IV4.9%

AJCC UNK0.1%

N/A0.7%

*Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere

FEMALE BREAST CANCER2009-2013 ANALYTIC CASES TREATMENT BY STAGE

AJCC 0 (555) AJCC I (1095) AJCC II (732) AJCC III (301) AJCC IV (139)

Surgery Only 51.3 15.1 5.9 5.3 0.7

Radiation Only 0 0 0 0.3 3.6

Chemotherapy Only 0 0 0.1 1.3 10.1

Hormone Only 0 0.1 0.4 0.3 8.6

Surgery & Radiation 18.9 7.7 2.9 1.0 0

Surgery & Chemotherapy 0 4.5 11.0 4.3 6.5

Surgery & Hormone 12.8 24.7 9.8 1.0 7.2

Surgery, Radiation & Hormone 15.5 30.0 13.5 4.7 2.2

Surgery, Radiation & Chemotherapy 0 5.9 15.2 20.6 2.2

Surgery, Chemotherapy, & Hormone 0.2 4.8 9.3 6.3 6.4

Surgery, Radiation, Chemotherapy, & Hormone 0.4 4.7 27.6 49.6 10.1

Other Combinations 0.2 2.0 3.5 5.3 36.7**

Not Treated 0.7 0.5 0.8 0 5.7

100% 100% 100% 100% 100%

*Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere**Other treatment combinations include: Radiation/Chemotherapy/Hormone; Chemotherapy/Hormone/Immunotherapy; Radiation/Chemotherapy; Radiation/Hormone; Chemotherapy/Hormone

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL 2003 - 2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (686) 1 0.9911 0.981 0.967 0.944 0.924

SEER (57544) 1 0.99 0.976 0.956 0.937 0.916

NCDB (209467) 1 0.991 0.977 0.96 0.942 0.922

87%

89%

91%

93%

95%

97%

99%

AJCC I

PER

CEN

TAG

E

©2014 NCDB, CoC©SEER; SEER*STAT

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL 2003 - 2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (567) 1 0.9891 0.9707 0.9393 0.912 0.888

SEER (43927) 1 0.98 0.949 0.914 0.881 0.85

NCDB (152007) 1 0.98 0.95 0.916 0.884 0.854

78%

83%

88%

93%

98%

AJCC II

PERC

ENTA

GE

©2014 NCDB, CoC©SEER; SEER*STAT

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL 2003 - 2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (197) 1 0.975 0.887 0.829 0.766 0.697

SEER (16433) 1 0.946 0.866 0.792 0.736 0.677

NCDB (57722) 1 0.943 0.858 0.782 0.719 0.667

5%15%25%35%45%55%65%75%85%95%

AJCC III

PERC

ENTA

GE

©2014 NCDB, CoC©SEER; SEER*STAT

FEMALE BREAST CANCER 5-YEAR OBSERVED SURVIVAL 2003 - 2006JHH vs. SEER vs. NCDB

YR 0 YR 1 YR 2 YR 3 YR 4 YR 5

JHH (84) 1 0.7246 0.615 0.4674 0.3321 0.2337

SEER (6652) 1 0.637 0.477 0.356 0.269 0.211

NCDB (20740) 1 0.649 0.479 0.358 0.271 0.211

5%15%25%35%45%55%65%75%85%95%

AJCC IV

PERC

ENTA

GE

©2014 NCDB, CoC©SEER; SEER*STAT